Scandic Hotels Group AB (0RD7)
London Stock Exchange · UK · prices in SEK · close of 27 Oct 2026
Key indicators
| Last close | SEK 100.50 |
|---|---|
| 52-week range | 78.50 – 102.18 |
| Return, 1 month / 3 months | +13.2% / +20.3% |
| Return, 1 year / 3 years | +17.9% / +191.5% |
| Trend | Uptrend |
| RSI (14) | 66 |
| Volatility (1 year) | 30.5% |
| Worst drawdown (1 year) | -18.3% |
| Average daily value traded | 8.28M SEK |
| Dividend yield | 2.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Scandic Hotels Group is a hotel company based in Stockholm, Sweden, that runs a chain of hotels across the Nordic countries and other parts of northern Europe. Its hotels serve business travellers, conference guests and leisure visitors, offering rooms, meeting facilities, restaurants and related hospitality services. The group operates properties under the Scandic name and a few related brands, with many hotels run under management or franchise arrangements alongside leased and owned sites.
On this site Scandic Hotels Group AB appears as a stock on the London Stock Exchange (UK), code 0RD7, with prices in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Scandic Hotels Group AB (0RD7) trades on the London Stock Exchange in UK. It last closed at SEK 100.50 on 27 October 2026.
Its price-based Market X-Ray is 68 out of 100 (a fair price profile), ranking 711 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 17.9% and over the last three months it rose 20.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 78 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 13.6% | ||
| From 52-week high | -1.6% | ||
| Momentum | 70 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 20.3% | ||
| 6-month return | 10.3% | ||
| 12-month return, skipping the last month | 4.1% | ||
| Stability (higher is calmer) | 69 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 30.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.3% | ||
| Liquidity | 72 · Strong | Trades actively. | |
| Average daily value traded | 8.28M SEK | ||
| Zero-volume days | 3.3% | ||
| Income | 26 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.6% | ||
| Years with dividends | 3 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −1.2% |
|---|---|
| 1 month | +13.2% |
| 3 months | +20.3% |
| 6 months | +10.3% |
| 1 year | +17.9% |
| 3 years | +191.5% |
| 5 years | +190.6% |
Signals
| 50-day / 200-day average | 91.97 / 88.45 |
|---|---|
| Golden / death cross (60 days) | Golden, 13 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5.43 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 6 May 2026 | SEK 1.3000 |
| 7 Nov 2025 | SEK 1.3000 |
| 7 May 2025 | SEK 1.3000 |
| 12 Dec 2024 | SEK 2.5000 |
| 25 Oct 2019 | SEK 1.7500 |
| 8 May 2019 | SEK 1.7500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.